Raludotatug

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T81313-1mg	1 mg				5 - 10 business days*	233.00€
TGM-T81313-5mg	5 mg				5 - 10 business days*	588.00€
TGM-T81313-10mg	10 mg	-	-	-	5 - 10 business days*	943.00€
TGM-T81313-25mg	25 mg	-	-	-	5 - 10 business days*	1,393.00€
TGM-T81313-50mg	50 mg	-	-	-	5 - 10 business days*	1,877.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Raludotatug is a humanized immunoglobulin G1-kappa (IgG1kappa) monoclonal antibody... more

Close menu

Product information "Raludotatug"

Description: Raludotatug is a humanized immunoglobulin G1-kappa (IgG1kappa) monoclonal antibody that exhibits antineoplastic properties through its specific targeting of cadherin-6 (CDH6), and when conjugated to a cytotoxic payload to form the antibody-drug conjugate Raludotatug deruxtecan.Raludotatug has demonstrated promising research potential in heavily pretreated, platinum-sensitive ovarian cancer. Target: Cadherin. References: Suzuki H, et al. Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models. Mol Cancer Ther. 2024 Mar 4,23(3):257-271.